Sublingual Semaglutide (generic Ozempic®) now available! Get Started
Dashboard
Compound Catalog

Ramelteon Hydrate

Ramelteon Hydrate is a potent active pharmaceutical ingredient primarily used in the management of sleep disorders, particularly insomnia. As a selective melatonin receptor agonist, it mimics the action of melatonin, a natural hormone that regulates the sleep-wake cycle, thereby promoting the onset of sleep without causing dependency.

Unlike traditional sedative-hypnotics, Ramelteon Hydrate does not act on the central nervous system's GABA receptors, reducing the risk of side effects such as cognitive impairment or withdrawal symptoms. This makes it a favorable option for patients seeking a non-habit-forming solution to improve sleep quality.

Trusted by 60,357 patients to date.
A group of faces of our past satisfied patients.
A svg symbol of a mortar and pestle with ingredients going in.
Custom made in our compounding labs.
Sliders that show the customization of ingredients.
Personalized treatment for better results.
User with a gear showing the personalization of the formulation.
All strengths and ingredients are tailored to your needs.
This medication is not available at retail pharmacies. It is compounded, and may be more effective at treating you or your patient.
This is some text inside of a div block.
Loading icon rotating.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Active Ingredient Information

A small arrow pointing down

Ramelteon Hydrate is a potent active pharmaceutical ingredient primarily used in the management of sleep disorders, particularly insomnia characterized by difficulty with sleep onset. As a selective melatonin receptor agonist, Ramelteon Hydrate mimics the action of melatonin, a natural hormone that regulates the sleep-wake cycle, by binding to MT1 and MT2 receptors in the brain. This mechanism of action helps to promote sleep by facilitating the body's natural circadian rhythm, making it a valuable option for patients who struggle with falling asleep.

Unlike many other sleep aids, Ramelteon Hydrate does not exhibit affinity for GABA receptors, which are commonly targeted by traditional sedative-hypnotics. This unique property reduces the risk of dependency and minimizes the potential for abuse, making it a safer alternative for long-term use. Additionally, Ramelteon Hydrate is not associated with significant next-day residual effects, allowing patients to maintain optimal cognitive and motor function upon waking. Its favorable safety profile and efficacy in improving sleep onset make it a preferred choice for healthcare providers seeking to address insomnia without the drawbacks of conventional sleep medications.

Formulas using

Ramelteon Hydrate

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.